NNSA Mo-99 Stakeholders Meeting
November 3-4, 2021
The 2021 NNSA Mo-99 Stakeholders Meeting was held via Zoom video conference on Wednesday, November 3 and Thursday, November 4, 2021, from 12:30 to 4:00 pm Eastern time.
Day One: Wednesday, November 3 | ||
---|---|---|
12:30 pm | Welcome and Introductions | Joanie Dix, National Nuclear Security Administration, Office of Conversion |
12:45 pm | U.S. Government Mo-99 Program Updates | Max Postman, National Nuclear Security Administration |
1:45 pm | Break | |
2:00 pm | Mo-99 Producer Updates | Eric Schutt, Rachel Houseman, and Tracy Radel, SHINE Medical Technologies Jim Harvey, NorthStar Medical Radioisotopes Terry Grimm and Mike Zamiara, Niowave Erik Nygaard, BWX Technologies |
3:45 pm | Adjourn | Max Postman, National Nuclear Security Administration |
Day Two: Thursday, November 4 | ||
---|---|---|
12:30 pm | U.S. Mo-99 Supply Status — Industry Perspectives | Roy Brown, Curium Pharma David Pelliciarini, Cardinal Health John Witkowski, United Pharmacy Partners (UPPI) (View PDF) Leah Gannon, Vizient Ira Goldman, Lantheus / Nuclear Medicine Europe Security of Supply Working Group |
2:15 pm | Break | |
2:30 pm | Open Discussion of Mo-99 International Symposium | Max Postman, National Nuclear Security Administration |
3:00 pm | Open Floor for General Stakeholder Comments/ Remarks | Max Postman, National Nuclear Security Administration |
3:30 pm | Closing Remarks/Adjourn | Joanie Dix, National Nuclear Security Administration |
Questions?
Please address inquiries to:
Dr. John W. Holland
Argonne National Laboratory
Phone: +1 (630) 252-3079
Email: [email protected]